Swiss Life Funds (LUX) Equity Global High Dividend CHF R Dis

Performance (in CHF)

Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.

Performance

1 month -3.46%
Current year 2.30%
3 years p.a. 3.54%
5 years p.a. 2.20%
10 years p.a. 4.17%
Since inception p.a. n.a.

Rolling performance in %

Key figures

YTD 1 year 3 years 5 years 10 years
Performance 2.30% -1.80% 11.00% 11.50% 50.53%
Maximum profit on monthly basis 4.39% 4.39% 6.20% 10.24% 10.81%
Maximum loss on monthly basis 1.51% -7.98% -7.98% -7.98% -11.32%
Max drawdown -5.40% -12.73% -14.13% -14.81% -32.10%
Volatility 11.60% 12.20% 10.68% 11.35% 13.40%
Sharpe ratio 0.54 -0.30 0.05 0.04 0.26
Maximum continuous profit in months 2 2 3 3 4
Maximum continuous loss in months 0 2 3 4 4
Positive months / profit duration in months 3 8 21 34 67
Negative months / loss duration in months 0 5 16 27 54

Master data

Fund name Swiss Life Funds (LUX) Equity Global High Dividend CHF R Dis
Fund management company Swiss Life Asset Managers Luxembourg
Fund domicile Luxembourg
Inception date 08 July 2008
ISIN LU0371451146
Swiss security no. 4323797
Fund currency CHF
Appropriation of income distributing
Issuing commission
Ongoing charges under PRIIP KID as at 01 January 2026 1.65%
End of financial year 31 August
Paying agent UBS Switzerland AG
Representative in Switzerland Swiss Life Asset Management AG
Fund volume as at 31 December 2025 160.09 Mio. CHF
Net asset value (NAV) as at 30 March 2026 79.73 CHF

Portfolio structure

Top holdings of fund volume (in %)

Johnson & Johnson 2.49%
AbbVie, Inc. 2.38%
Procter & Gamble 2.31%
Cisco Systems, Inc. 2.26%
Exxon Mobil Corp. 2.26%
Home Depot 2.14%
Merck & Co. Inc. 1.80%
Novartis AG 1.77%
Unitedhealth Group, Inc. 1.71%
IBM Corp. 1.69%

Asset allocation

Currency

Countries

Sectors